Marsha Tennis

2.5k total citations
12 papers, 950 citations indexed

About

Marsha Tennis is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Marsha Tennis has authored 12 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Physiology and 4 papers in Psychiatry and Mental health. Recurrent topics in Marsha Tennis's work include Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Marsha Tennis is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Marsha Tennis collaborates with scholars based in United States, Switzerland and Germany. Marsha Tennis's co-authors include John H. Growdon, Bradley T. Hyman, Michael C. Irizarry, Joseph J. Locascio, Hiroaki Fukumoto, David Schoenfeld, Meihua Deng, Roger M. Nitsch, Steven M. Greenberg and Joseph Ghika and has published in prestigious journals such as Neurology, Annals of Neurology and Movement Disorders.

In The Last Decade

Marsha Tennis

12 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marsha Tennis United States 11 505 293 225 188 177 12 950
Alessia Lanari Italy 20 547 1.1× 414 1.4× 261 1.2× 175 0.9× 468 2.6× 34 1.7k
Alessandra Bizzarro Italy 18 349 0.7× 204 0.7× 216 1.0× 154 0.8× 111 0.6× 40 886
Ulrike Mann Germany 16 481 1.0× 254 0.9× 417 1.9× 157 0.8× 143 0.8× 26 1.2k
Alastair Mander Australia 7 510 1.0× 176 0.6× 254 1.1× 167 0.9× 97 0.5× 10 1.1k
Giuseppe Gambina Italy 22 483 1.0× 342 1.2× 232 1.0× 259 1.4× 58 0.3× 50 1.3k
Gerard D. Schellenberg United States 18 841 1.7× 438 1.5× 486 2.2× 184 1.0× 144 0.8× 30 1.7k
Tomas Müller‐Thomsen Germany 14 435 0.9× 252 0.9× 342 1.5× 135 0.7× 65 0.4× 21 1.0k
Marina Zvartau‐Hind United States 11 785 1.6× 223 0.8× 423 1.9× 304 1.6× 148 0.8× 22 1.4k
Eugene Hone Australia 18 760 1.5× 277 0.9× 380 1.7× 100 0.5× 104 0.6× 37 1.3k
Anita Garlind Sweden 17 782 1.5× 123 0.4× 502 2.2× 263 1.4× 119 0.7× 30 1.7k

Countries citing papers authored by Marsha Tennis

Since Specialization
Citations

This map shows the geographic impact of Marsha Tennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marsha Tennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marsha Tennis more than expected).

Fields of papers citing papers by Marsha Tennis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marsha Tennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marsha Tennis. The network helps show where Marsha Tennis may publish in the future.

Co-authorship network of co-authors of Marsha Tennis

This figure shows the co-authorship network connecting the top 25 collaborators of Marsha Tennis. A scholar is included among the top collaborators of Marsha Tennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marsha Tennis. Marsha Tennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wills, Anne‐Marie, Shirley Eberly, Marsha Tennis, et al.. (2013). Caffeine consumption and risk of dyskinesia in CALM‐PD. Movement Disorders. 28(3). 380–383. 41 indexed citations
2.
Serrano‐Pozo, Alberto, Gloria Lena Vega, Dieter Lütjohann, et al.. (2010). Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers. Alzheimer Disease & Associated Disorders. 24(3). 220–226. 60 indexed citations
3.
Irizarry, Michael C., M. Edip Gurol, Susan Raju, et al.. (2005). Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease. Neurology. 65(9). 1402–1408. 124 indexed citations
4.
Fukumoto, Hiroaki, Marsha Tennis, Joseph J. Locascio, et al.. (2003). Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels. Archives of Neurology. 60(7). 958–958. 228 indexed citations
5.
Greenberg, Steven M., Marsha Tennis, Laura B. Brown, et al.. (2000). Donepezil Therapy in Clinical Practice. Archives of Neurology. 57(1). 94–94. 132 indexed citations
6.
Nitsch, Roger M., Meihua Deng, Marsha Tennis, David Schoenfeld, & John H. Growdon. (2000). The selective muscarinic M1 agonist AF102B decreases levels of total Aβ in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 48(6). 913–918. 1 indexed citations
7.
Nitsch, Roger M., Meihua Deng, Marsha Tennis, David Schoenfeld, & John H. Growdon. (2000). The selective muscarinic M1 agonist AF102B decreases levels of total A? in cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 48(6). 913–918. 121 indexed citations
8.
Growdon, John H., et al.. (1997). Pupil Dilation to Tropicamide Is Not Specific for Alzheimer Disease. Archives of Neurology. 54(7). 841–844. 16 indexed citations
9.
Nitsch, Roger M., G. William Rebeck, Meihua Deng, et al.. (1995). Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype. Annals of Neurology. 37(4). 512–518. 94 indexed citations
10.
Ghika, Joseph, et al.. (1995). Environment-driven responses in progressive supranuclear palsy. Journal of the Neurological Sciences. 130(1). 104–111. 37 indexed citations
11.
Kieburtz, Karl, Michael McDermott, Peter G. Como, et al.. (1994). The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurology. 44(9). 1756–1756. 42 indexed citations
12.
Ghika, Joseph, et al.. (1991). Idazoxan treatment in progressive supranuclear palsy. Neurology. 41(7). 986–986. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Lanari Breakdown of academic impact, for papers by Alessandra Bizzarro Breakdown of academic impact, for papers by Ulrike Mann Breakdown of academic impact, for papers by Alastair Mander Breakdown of academic impact, for papers by Giuseppe Gambina Breakdown of academic impact, for papers by Gerard D. Schellenberg Breakdown of academic impact, for papers by Tomas Müller‐Thomsen Breakdown of academic impact, for papers by Marina Zvartau‐Hind Breakdown of academic impact, for papers by Eugene Hone Breakdown of academic impact, for papers by Anita Garlind
Rankless by CCL
2026